查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美微生物鑑定方法市场预测至 2030 年 - 区域分析 - 按方法和类型
市场调查报告书
商品编码
1481977

北美微生物鑑定方法市场预测至 2030 年 - 区域分析 - 按方法和类型

North America Microbial Identification Methods Market Forecast to 2030 - Regional Analysis - By Method and Type
出版日期: | 出版商: The Insight Partners | 英文 96 Pages | 订单完成后即时交付

价格

2022年北美微生物鑑定方法市值为211183万美元，预计2030年将达到331978万美元；预计2022年至2030年复合年增长率为5.8%。

日益增长的食品安全问题对微生物鑑定程序的需求推动了北美微生物鑑定方法市场的发展

食源性疾病 (FBD) 是一个普遍存在且不断扩大的公共卫生和经济问题。食源性感染的流行受到近期食品生产和加工方法的变化以及消费者不断变化的饮食模式的影响。感染过程中已知病原体之间的相互作用是人们关注的问题之一，近年来又出现了新的困难。儘管越来越多地采用化学防腐剂、冷链以及对微生物的更多了解，但食源性疾病对于工业化国家和发展中国家来说都是一个重大的公共卫生问题。粮食安全集群估计，每年约有 42 万人死亡，超过 6 亿人（全球近十分之一的人）在食用受污染的食品后生病，导致 2022 年 6 月损失 3,300 万伤残调整生命年。

根据美国疾病管制与预防中心 (CDC) 2019 年的数据，每年，美国约有六分之一的人患有食源性疾病。沙门氏菌、大肠桿菌、弯曲桿菌和李斯特菌等细菌是许多食源性感染的原因。该国每年因食源性感染导致约 10 万人入院治疗和 3,000 人死亡。此外，每年有 400 万加拿大人（即八分之一的加拿大人）因受污染的食物而生病。据估计，每年有 11,500 人因食源性疾病入院，240 人死亡。数字中包含了 30 种食源性病原体和不明原因的急性胃肠道疾病的估计。传统方法是使用各种非选择性和选择性富集技术培养细菌，然后进行生化确认等。检测时间是检测食品时的重大限制，特别是那些保质期较短的食品，如新鲜肉类、鱼类、乳製品和蔬菜。几种较新的检测方法使用光谱方法，例如基质辅助雷射解吸电离飞行时间和高光谱成像协议。因此，食源性疾病病例的增加正在推动微生物鑑定方法市场。

北美微生物鑑定方法市场概况

由于医疗保健、製药、食品和饮料以及环境监测等各个行业对准确、快速微生物鑑定的需求激增，北美微生物鑑定方法市场在过去几年中经历了大幅增长。这一增长归因于多种因素，包括传染病发病率的上升、食品和药品生产中严格品质控制措施的需要，以及人们日益认识到微生物监测在维护公众健康方面的重要性。根据 CDC 2022 年 11 月的最新情况，与冷冻沙拉三明治有关的大肠桿菌爆发导致 20 起病例和 5 起住院病例。

此外，技术的进步、创新微生物鑑定方法的引入以及重要参与者的存在预计将支持未来几年的市场扩张。例如，BD Kiestra IdentifA系统旨在自动化准备微生物学细菌鑑定测试，于2022年1月获得FDA 510(k)许可。系统从阳性血液培养物中快速辨识超过425 种细菌。此外，自动化和人工智慧 (AI) 对于简化识别流程、减少人为错误和提高整体效率至关重要。製药和生物技术领域是北美微生物鑑定市场成长的主要贡献者。药物开发、品质控制和法规遵循对微生物的精确鑑定的需要导致了对先进鑑定方法的高需求。因此，各种最终用户对准确、快速微生物鑑定的需求不断增加，传染病发病率不断上升，食品和药品生产中严格品质控制措施的需要，以及对微生物监测在维护公众健康方面的重要性的日益认识，这些都是迫切需要解决的问题。

北美微生物鑑定方法市场收入及 2030 年预测（百万美元）

北美微生物鑑定方法市场细分

北美微生物鑑定方法市场根据方法、类型和国家进行细分。

根据方法，北美微生物鑑定方法市场分为基因型、表现型和蛋白质型。 2022 年，表型细分市场占最大份额。表型部分再细分为仪器、试剂盒、试剂。蛋白型部分再细分为仪器、试剂盒、试剂。

依类型划分，北美微生物鑑定方法市场分为细菌鑑定係统、微生物计数系统、细菌抗药性鑑定係统、微生物分析仪等。 2022 年，细菌辨识系统领域占最大份额。

根据国家/地区，北美微生物鑑定方法市场分为美国和加拿大。 2022 年，美国将主导北美微生物鑑定方法市场。

Accelerate Diagnostics Inc、Avantor Inc、Becton Dickinson and Co、bioMerieux SA、Bruker Corp、Danaher Corp、Merck KGaA、Molzym GmbH & Co KG、Shimadzu Corp、Thermo Fisher Scientific Inc 是北美微生物鑑定领域的一些领先公司方法市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美微生物鑑定方法市场模式

  • 概述
  • 北美 PEST 分析

第 5 章：北美微生物鑑定方法市场 - 主要产业动态

  • 市场驱动因素
    • 日益关注的食品安全问题要求微生物鑑定程序
    • 不同最终用户对微生物鑑定方法的需求不断增长
  • 市场限制
    • 自动化微生物辨识系统成本高昂
    • 由于复杂的规范架构，新微生物诊断测试的批准程序被推迟
  • 市场机会
    • 政府促进微生物鑑定的措施和资金
  • 未来的趋势
    • 微生物鑑定技术的进步
  • 影响分析：

第 6 章：微生物鑑定方法市场 - 北美市场分析

  • 北美微生物鑑定方法市场收入，2020 - 2030

第 7 章：北美微生物鑑定方法市场 - 收入和 2030 年预测 - 按方法

  • 概述
  • 北美微生物鑑定方法市场收入份额，依方法 2022 年和 2030 年 (%)
  • 基因型
  • 表型
  • 蛋白质型

第 8 章：北美微生物鑑定方法市场 - 收入和 2030 年预测 - 按类型

  • 概述
  • 北美微生物鑑定方法市场收入份额，按类型 2022 年和 2030 年 (%)
  • 细菌辨识系统
  • 微生物计数系统
  • 细菌抗药性辨识系统
  • 微生物分析仪
  • 其他的

第 9 章：北美微生物鑑定方法市场 - 国家分析

  • 北美洲
    • 我们
    • 加拿大

第 10 章：北美微生物鑑定方法市场产业格局

  • 概述
  • 北美微生物鑑定方法市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 11 章：公司简介

  • Avantor Inc
  • Becton Dickinson and Co
  • Danaher Corp
  • bioMerieux SA
  • Merck KGaA
  • Thermo Fisher Scientific Inc
  • Bruker Corp
  • Shimadzu Corp
  • Accelerate Diagnostics Inc
  • Molzym GmbH & Co KG
  • Biolog Inc

第 12 章：附录

Product Code: BMIRE00029664

The North America microbial identification methods market was valued at US$ 2,111.83 million in 2022 and is expected to reach US$ 3,319.78 million by 2030; it is estimated to grow at a CAGR of 5.8% from 2022 to 2030.

Increasing Food Safety Concerns Demanding for Microbial Identification Procedure Fuel the North America Microbial Identification Methods Market

Foodborne diseases (FBD) are a prevalent and expanding public health and economic problem. The prevalence of foodborne infections is influenced by recent changes in food production and processing methods and consumers' ever-evolving eating patterns. The interaction between known pathogens during infection is one of the concerns, and new difficulties have emerged in recent years. Despite the rising adoption of chemical preservatives, cold chains, and a greater understanding of microbes, foodborne illnesses are a significant public health issue for both industrialized and developing nations. The Food Security Cluster estimates that each year, ~420,000 people die, and over 600 million people-nearly one in ten people worldwide-get sick after consuming contaminated food, resulting in a loss of 33 million DALYs in June 2022.

As per the Centers for Disease Control and Prevention (CDC) 2019, every year, about 1 in 6 people in the US have a foodborne disease. Bacteria, such as Salmonella, E. Coli, Campylobacter, and Listeria, are the cause of many foodborne infections. Foodborne infections cause about 100,000 hospital admissions and 3,000 fatalities annually in the country. Additionally, every year, 4 million Canadians, or 1 in 8 of the population, become ill from contaminated food. An estimated 11,500 hospital admissions and 240 fatalities are attributed to foodborne diseases annually. Both estimates for 30 foodborne pathogens and unidentified causes of acute gastrointestinal sickness are included in the numbers. The conventional approach is cultivating bacteria using a variety of nonselective and selective enrichment techniques, followed, among other things, by biochemical confirmation. The time-to-detection is a significant limitation when testing foods, especially those with short shelf lives like fresh meat, fish, dairy products, and vegetables. Several newer detection methods use spectroscopic approaches, such as matrix-assisted laser desorption ionization-time of flight and hyperspectral imaging protocols. Thus, the increase in cases of foodborne diseases is driving the microbial identification methods market.

North America Microbial Identification Methods Market Overview

The North America microbial identification method market has experienced substantial growth in the past few years due to an upsurge in demand for accurate and rapid microbial identification across various industries such as healthcare, pharmaceuticals, food & beverages, and environmental monitoring. The growth is attributed to several factors, including the rising incidence of infectious diseases, the need for stringent quality control measures in food and pharmaceutical production, and the growing awareness of the importance of microbial monitoring in maintaining public health. The E. coli outbreak connected to frozen falafel resulted in 20 instances of sickness and five hospitalizations, according to a November 2022 update from the CDC.

Furthermore, advancements in technology, the introduction of innovative microbial identification methods, and the existence of significant players are anticipated to support the market expansion in the coming years. For instance, the BD Kiestra IdentifA system, intended to automate the preparation of microbiology bacterial identification testing, received 510(k) clearance by the FDA in January 2022. In addition, Bruker Corporation, a US-based organization, introduced the MBT Sepsityper Kit IVD in January 2021 to quickly identify more than 425 bacteria from positive blood cultures using the MALDI Biotyper CA System. Additionally, automation and artificial intelligence (AI) are pivotal in streamlining the identification process, reducing human error, and improving overall efficiency. The pharmaceutical and biotechnology sectors are major contributors to the growth of the microbial identification market in North America. The need for precise identification of microorganisms for drug development, quality control, and regulatory compliance has led to a high demand for advanced identification methods. Thus, increasing demand for accurate and rapid microbial identification across various end users, rising incidence of infectious diseases, the need for stringent quality control measures in food and pharmaceutical production, and the growing awareness of the importance of microbial monitoring in maintaining public health are a few other factors driving the market in North America.

North America Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Million)

North America Microbial Identification Methods Market Segmentation

The North America microbial identification methods market is segmented based on method, type, and country.

Based on method, the North America microbial identification methods market is segmented into genotypic, phenotypic, and proteotypic. The phenotypic segment held the largest share in 2022. The genotypic segment is further subsegmented into instruments, kits, reagents. The phenotypic segment is further subsegmented into instruments, kits, reagents. The proteotypic segment is further subsegmented into instruments, kits, reagents.

By type, the North America microbial identification methods market is segmented into bacterial identification system, microbial enumeration system, bacterial resistance identification systems, microbiology analyzer, and others. The bacterial identification system segment held the largest share in 2022.

Based on country, the North America microbial identification methods market is bifurcated into the US and Canada. The US dominated the North America microbial identification methods market in 2022.

Accelerate Diagnostics Inc, Avantor Inc, Becton Dickinson and Co, bioMerieux SA, Bruker Corp, Danaher Corp, Merck KGaA, Molzym GmbH & Co KG, Shimadzu Corp, Thermo Fisher Scientific Inc are some of the leading companies operating in the North America microbial identification methods market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Microbial Identification Methods Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis

5. North America Microbial Identification Methods Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Food Safety Concerns Demanding for Microbial Identification Procedure
    • 5.1.2 Rising Demand for Microbial Identification Methods Across Various End Users
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Automated Microbial Identification Systems
    • 5.2.2 Delay in Approval Process of New Microbial Diagnostic Test Due to Complex Regulatory Framework
  • 5.3 Market Opportunities
    • 5.3.1 Government Initiatives and Funding to Promote Microbial Identification
  • 5.4 Future Trends
    • 5.4.1 Advancements in Microbial Identification Techniques
  • 5.5 Impact Analysis:

6. Microbial Identification Methods Market - North America Market Analysis

  • 6.1 North America Microbial Identification Methods Market Revenue (US$ Mn), 2020 - 2030

7. North America Microbial Identification Methods Market - Revenue and Forecast to 2030 - by Method

  • 7.1 Overview
  • 7.2 North America Microbial Identification Methods Market Revenue Share, by Method 2022 & 2030 (%)
  • 7.3 Genotypic
    • 7.3.1 Overview
    • 7.3.2 Genotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 North America Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
      • 7.3.2.2 North America Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
  • 7.4 Phenotypic
    • 7.4.1 Overview
    • 7.4.2 Phenotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 North America Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
      • 7.4.2.2 North America Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
  • 7.5 Proteotypic
    • 7.5.1 Overview
    • 7.5.2 Proteotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.1 North America Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
      • 7.5.2.2 North America Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)

8. North America Microbial Identification Methods Market - Revenue and Forecast to 2030 - by Type

  • 8.1 Overview
  • 8.2 North America Microbial Identification Methods Market Revenue Share, by Type 2022 & 2030 (%)
  • 8.3 Bacterial Identification Systems
    • 8.3.1 Overview
    • 8.3.2 Bacterial Identification Systems: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Microbial Enumeration Systems
    • 8.4.1 Overview
    • 8.4.2 Microbial Enumeration System: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Bacterial Resistance Identification Systems
    • 8.5.1 Overview
    • 8.5.2 Bacterial Resistance Identification Systems: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Microbiology Analyzers
    • 8.6.1 Overview
    • 8.6.2 Microbiology Analyzer: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Microbial Identification Methods Market - Country Analysis

  • 9.1 North America
    • 9.1.1 North America Microbial Identification Methods Market, by Country
      • 9.1.1.1 US
        • 9.1.1.1.1 US: North America Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.1.2 US: North America Microbial Identification Methods Market, by Method
        • 9.1.1.1.2.1 US: North America Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.1.2.2 US: North America Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.1.2.3 US: North America Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.1.2.4 US: North America Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.1.2.5 US: North America Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.1.2.6 US: North America Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.1.3 US: North America Microbial Identification Methods Market, by Type
      • 9.1.1.2 Canada
        • 9.1.1.2.1 Canada: North America Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.2 Canada: North America Microbial Identification Methods Market, by Method
        • 9.1.1.2.2.1 Canada: North America Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.2.2.2 Canada: North America Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.2.2.3 Canada: North America Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.2.2.4 Canada: North America Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.2.2.5 Canada: North America Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.2.2.6 Canada: North America Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.2.3 Canada: North America Microbial Identification Methods Market, by Type

10. North America Microbial Identification Methods Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the North America Microbial Identification Methods Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Avantor Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Becton Dickinson and Co
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Danaher Corp
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 bioMerieux SA
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Merck KGaA
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Thermo Fisher Scientific Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Bruker Corp
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Shimadzu Corp
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Accelerate Diagnostics Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Molzym GmbH & Co KG
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Biolog Inc
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. North America Microbial Identification Methods Market Segmentation
  • Table 2. North America Microbial Identification Methods Market, by Genotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Microbial Identification Methods Market, by Genotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Microbial Identification Methods Market, by Phenotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Microbial Identification Methods Market, by Phenotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Microbial Identification Methods Market, by Proteotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Microbial Identification Methods Market, by Proteotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn) - Methods
  • Table 9. US: North America Microbial Identification Methods Market, by Genotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US: North America Microbial Identification Methods Market, by Genotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US: North America Microbial Identification Methods Market, by Phenotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US: North America Microbial Identification Methods Market, by Phenotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US: North America Microbial Identification Methods Market, by Proteotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. US: North America Microbial Identification Methods Market, by Proteotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. US: North America Microbial Identification Methods Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 16. Canada: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn) - Method
  • Table 17. Canada: North America Microbial Identification Methods Market, by Genotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada: North America Microbial Identification Methods Market, by Genotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Canada: North America Microbial Identification Methods Market, by Phenotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Canada: North America Microbial Identification Methods Market, by Phenotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Canada North America Microbial Identification Methods Market, by Proteotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Canada: North America Microbial Identification Methods Market, by Proteotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Canada: North America Microbial Identification Methods Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 24. Recent Inorganic Growth Strategies in the North America Microbial Identification Methods Market
  • Table 25. Recent Organic Growth Strategies in the North America Microbial Identification Methods Market
  • Table 26. Glossary of Terms, North America Microbial Identification Methods Market

List Of Figures

  • Figure 1. North America Microbial Identification Methods Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. North America Microbial Identification Methods Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Microbial Identification Methods Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. North America Microbial Identification Methods Market Revenue Share, by Method 2022 & 2030 (%)
  • Figure 7. Genotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Phenotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Proteotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. North America Microbial Identification Methods Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 11. Bacterial Identification System: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Microbial Enumeration System: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Bacterial Resistance Identification Systems: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Microbiology Analyzer: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Microbial Identification Methods Market, 2022 ($Mn)
  • Figure 17. North America Microbial Identification Methods Market, By Key Countries, 2022 And 2030 (%)
  • Figure 18. US: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 19. Canada: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 20. Growth Strategies in the North America Microbial Identification Methods Market